Janssen Korea to launch Velcade, a new cancer drug.

Janssen Korea announced that an anti-cancer drug of new mode of action, Velcade (bortezomib) injection, would be launched from Sept. 1 for the treatment of multiple myeloma. Velcade is the new anti-cancer drug by irreversibly blocking the activity of proteazome, a protease of breaking the protein linked with cell division.

Last year U. S. FDA exceptionally approved its registration only wit...